Benchmark against your competition
Understand how AI crawlers access your site
See where AI gets info about you
Track the queries mentioning your brand
Own your AI narrative
Add GEO to your service offerings
Get recommended in shopping queries
Monitor AI mentions at scale
CRISPR Therapeutics
What AI says about CRISPR Therapeutics
CRISPR Therapeutics is at the forefront of gene editing technology, focusing on developing transformative therapies for serious diseases such as sickle cell disease and cancer. With a diverse portfolio of programs, the company aims to revolutionize medicine through innovative gene-based treatments.
Is this your brand?
Claim this profile to keep your information accurate and add what's missing.
Products & Services
Gene-Based Medicines
Therapies developed using CRISPR technology to treat serious diseases, including hemoglobinopathies, oncology, autoimmune diseases, and more.
CRISPR/Cas9 Therapy
The first-ever approved CRISPR-based therapy for sickle cell disease and transfusion-dependent beta thalassemia.
Common Questions
What is CRISPR Therapeutics?
CRISPR Therapeutics is a biotechnology company focused on developing gene-based medicines using CRISPR technology to treat serious diseases.
What diseases does CRISPR Therapeutics target?
The company targets a range of diseases including hemoglobinopathies, oncology, diabetes, and cardiovascular diseases.
What is the first approved CRISPR-based therapy?
The first approved CRISPR-based therapy is CASGEVY™ (exagamglogene autotemcel), which is used for treating sickle cell disease and transfusion-dependent beta thalassemia.
Where is CRISPR Therapeutics headquartered?
The global headquarters is located in Zug, Switzerland, with additional R&D facilities in Boston, MA, and Framingham, MA.
How does CRISPR technology work?
CRISPR technology allows for precise editing of genes, enabling the development of therapies that can correct genetic defects and treat diseases.